Ivo Bozovic, Sanja Gluscevic, Ivana Kezic, Vukan Ivanovic, Aleksa Palibrk, Stojan Peric, Ivana Basta, Zorica Stevic
{"title":"一名亨廷顿氏病患者的横纹肌萎缩性侧索硬化症:病例研究","authors":"Ivo Bozovic, Sanja Gluscevic, Ivana Kezic, Vukan Ivanovic, Aleksa Palibrk, Stojan Peric, Ivana Basta, Zorica Stevic","doi":"10.1186/s41983-024-00800-4","DOIUrl":null,"url":null,"abstract":"The rationale for this paper is a description of a patient from Southeast Europe with genetically confirmed Huntington’s disease (HD), coexisting with sporadic, bulbar-onset amyotrophic lateral sclerosis (ALS). To the best of our knowledge, the total number of reported cases with confirmed coexistence of HD and ALS is less than 20. Thus, it is an extremely rare condition speculated to be in a range from 2 to 6 per billion, and data from this part of the World are completely missing. Here we report a 72-year-old female with a family history of HD who had generalized chorea and hyperreflexia. Using the PCR-based test for the detection of the CAG triplet repeat expansion, the presence of HD was confirmed. After several months, our patient had progressively developed dysarthria and dysphagia, followed by spastic quadriparesis, generalized muscle wasting, spontaneous fasciculations and sialorrhea. The diagnosis of definite ALS was established based on the patient’s neurological status, electromyography findings and current El Escorial criteria. Our study emphasizes the need for the recognition of the co-occurrence of clinically distinct and rare genetic disorders, such as HD and ALS. New insights from the studies dealing with these rare topics could significantly contribute to the contest of new gene therapy trials.","PeriodicalId":74995,"journal":{"name":"The Egyptian journal of neurology, psychiatry and neurosurgery","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bulbar-onset amyotrophic lateral sclerosis in a patient with genetically confirmed Huntington’s disease: a case study\",\"authors\":\"Ivo Bozovic, Sanja Gluscevic, Ivana Kezic, Vukan Ivanovic, Aleksa Palibrk, Stojan Peric, Ivana Basta, Zorica Stevic\",\"doi\":\"10.1186/s41983-024-00800-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The rationale for this paper is a description of a patient from Southeast Europe with genetically confirmed Huntington’s disease (HD), coexisting with sporadic, bulbar-onset amyotrophic lateral sclerosis (ALS). To the best of our knowledge, the total number of reported cases with confirmed coexistence of HD and ALS is less than 20. Thus, it is an extremely rare condition speculated to be in a range from 2 to 6 per billion, and data from this part of the World are completely missing. Here we report a 72-year-old female with a family history of HD who had generalized chorea and hyperreflexia. Using the PCR-based test for the detection of the CAG triplet repeat expansion, the presence of HD was confirmed. After several months, our patient had progressively developed dysarthria and dysphagia, followed by spastic quadriparesis, generalized muscle wasting, spontaneous fasciculations and sialorrhea. The diagnosis of definite ALS was established based on the patient’s neurological status, electromyography findings and current El Escorial criteria. Our study emphasizes the need for the recognition of the co-occurrence of clinically distinct and rare genetic disorders, such as HD and ALS. New insights from the studies dealing with these rare topics could significantly contribute to the contest of new gene therapy trials.\",\"PeriodicalId\":74995,\"journal\":{\"name\":\"The Egyptian journal of neurology, psychiatry and neurosurgery\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Egyptian journal of neurology, psychiatry and neurosurgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s41983-024-00800-4\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Egyptian journal of neurology, psychiatry and neurosurgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41983-024-00800-4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
本文旨在描述一名来自东南欧的亨廷顿氏病(Huntington's disease,HD)患者,该患者经基因证实同时患有散发性、球部发病的肌萎缩性脊髓侧索硬化症(Amyotrophic lateral sclerosis,ALS)。据我们所知,确诊同时患有亨廷顿舞蹈症和肌萎缩性脊髓侧索硬化症的病例总数不到 20 例。因此,这是一种极为罕见的病症,据推测其发病率在十亿分之二到六之间,而世界上这一地区的数据却完全缺失。在此,我们报告了一名有 HD 家族史的 72 岁女性患者,她患有全身舞蹈症和反射亢进。通过基于 PCR 的 CAG 三重重复扩增检测,患者被确诊为 HD。几个月后,患者逐渐出现构音障碍和吞咽困难,继而出现痉挛性四肢瘫痪、全身肌肉萎缩、自发性筋膜痉挛和口疮。根据患者的神经系统状况、肌电图检查结果和当前的埃斯科里亚尔标准,确诊为 ALS。我们的研究强调,需要认识到临床上不同的罕见遗传性疾病(如 HD 和 ALS)同时存在的必要性。从有关这些罕见疾病的研究中获得的新见解将极大地促进新基因疗法试验的竞争。
Bulbar-onset amyotrophic lateral sclerosis in a patient with genetically confirmed Huntington’s disease: a case study
The rationale for this paper is a description of a patient from Southeast Europe with genetically confirmed Huntington’s disease (HD), coexisting with sporadic, bulbar-onset amyotrophic lateral sclerosis (ALS). To the best of our knowledge, the total number of reported cases with confirmed coexistence of HD and ALS is less than 20. Thus, it is an extremely rare condition speculated to be in a range from 2 to 6 per billion, and data from this part of the World are completely missing. Here we report a 72-year-old female with a family history of HD who had generalized chorea and hyperreflexia. Using the PCR-based test for the detection of the CAG triplet repeat expansion, the presence of HD was confirmed. After several months, our patient had progressively developed dysarthria and dysphagia, followed by spastic quadriparesis, generalized muscle wasting, spontaneous fasciculations and sialorrhea. The diagnosis of definite ALS was established based on the patient’s neurological status, electromyography findings and current El Escorial criteria. Our study emphasizes the need for the recognition of the co-occurrence of clinically distinct and rare genetic disorders, such as HD and ALS. New insights from the studies dealing with these rare topics could significantly contribute to the contest of new gene therapy trials.